Cargando…

Management of Patients with Graves' Disease and Orbital Involvement: Role of Spectral Domain Optical Coherence Tomography

PURPOSE: To investigate the role of choroidal thickness evaluation with spectral domain optical coherence tomography (SDOCT) and enhanced depth imaging (EDI) technique in the management of patients with Graves' disease and orbitopathy (GO). METHODS: Thirty-six eyes of 18 patients with GO and 36...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruscolini, Alice, La Cava, Maurizio, Gharbiya, Magda, Sacchetti, Marta, Restivo, Lucia, Nardella, Chiara, Marenco, Marco, Lambiase, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835242/
https://www.ncbi.nlm.nih.gov/pubmed/29670918
http://dx.doi.org/10.1155/2018/1454616
_version_ 1783303778143830016
author Bruscolini, Alice
La Cava, Maurizio
Gharbiya, Magda
Sacchetti, Marta
Restivo, Lucia
Nardella, Chiara
Marenco, Marco
Lambiase, Alessandro
author_facet Bruscolini, Alice
La Cava, Maurizio
Gharbiya, Magda
Sacchetti, Marta
Restivo, Lucia
Nardella, Chiara
Marenco, Marco
Lambiase, Alessandro
author_sort Bruscolini, Alice
collection PubMed
description PURPOSE: To investigate the role of choroidal thickness evaluation with spectral domain optical coherence tomography (SDOCT) and enhanced depth imaging (EDI) technique in the management of patients with Graves' disease and orbitopathy (GO). METHODS: Thirty-six eyes of 18 patients with GO and 36 eyes of 18 age-matched control subjects were included in this retrospective observational study. All the subjects underwent a complete ophthalmological evaluation, including clinical activity score (CAS) and exophthalmometry. The SDOCT images of the choroid were obtained by EDI modality. RESULTS: Choroidal thickness was significantly increased in GO than in control eyes (p < 0.01). A significant correlation was found between choroidal thickness and CAS, proptosis, and the duration of disease (p < 0.05). CONCLUSION: This study shows that choroidal thickness, evaluated with EDI-OCT, is significantly increased in patients with GO and correlates with the activity of the disease, proptosis, and duration of the disease. The choroidal thickening may reflect the ocular hemodynamic changes, and enhanced depth imaging optical coherence tomography may be a useful tool for the evaluation of orbital congestion and management of patients with Graves' disease and orbital involvement.
format Online
Article
Text
id pubmed-5835242
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-58352422018-04-18 Management of Patients with Graves' Disease and Orbital Involvement: Role of Spectral Domain Optical Coherence Tomography Bruscolini, Alice La Cava, Maurizio Gharbiya, Magda Sacchetti, Marta Restivo, Lucia Nardella, Chiara Marenco, Marco Lambiase, Alessandro J Immunol Res Research Article PURPOSE: To investigate the role of choroidal thickness evaluation with spectral domain optical coherence tomography (SDOCT) and enhanced depth imaging (EDI) technique in the management of patients with Graves' disease and orbitopathy (GO). METHODS: Thirty-six eyes of 18 patients with GO and 36 eyes of 18 age-matched control subjects were included in this retrospective observational study. All the subjects underwent a complete ophthalmological evaluation, including clinical activity score (CAS) and exophthalmometry. The SDOCT images of the choroid were obtained by EDI modality. RESULTS: Choroidal thickness was significantly increased in GO than in control eyes (p < 0.01). A significant correlation was found between choroidal thickness and CAS, proptosis, and the duration of disease (p < 0.05). CONCLUSION: This study shows that choroidal thickness, evaluated with EDI-OCT, is significantly increased in patients with GO and correlates with the activity of the disease, proptosis, and duration of the disease. The choroidal thickening may reflect the ocular hemodynamic changes, and enhanced depth imaging optical coherence tomography may be a useful tool for the evaluation of orbital congestion and management of patients with Graves' disease and orbital involvement. Hindawi 2018-02-18 /pmc/articles/PMC5835242/ /pubmed/29670918 http://dx.doi.org/10.1155/2018/1454616 Text en Copyright © 2018 Alice Bruscolini et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bruscolini, Alice
La Cava, Maurizio
Gharbiya, Magda
Sacchetti, Marta
Restivo, Lucia
Nardella, Chiara
Marenco, Marco
Lambiase, Alessandro
Management of Patients with Graves' Disease and Orbital Involvement: Role of Spectral Domain Optical Coherence Tomography
title Management of Patients with Graves' Disease and Orbital Involvement: Role of Spectral Domain Optical Coherence Tomography
title_full Management of Patients with Graves' Disease and Orbital Involvement: Role of Spectral Domain Optical Coherence Tomography
title_fullStr Management of Patients with Graves' Disease and Orbital Involvement: Role of Spectral Domain Optical Coherence Tomography
title_full_unstemmed Management of Patients with Graves' Disease and Orbital Involvement: Role of Spectral Domain Optical Coherence Tomography
title_short Management of Patients with Graves' Disease and Orbital Involvement: Role of Spectral Domain Optical Coherence Tomography
title_sort management of patients with graves' disease and orbital involvement: role of spectral domain optical coherence tomography
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835242/
https://www.ncbi.nlm.nih.gov/pubmed/29670918
http://dx.doi.org/10.1155/2018/1454616
work_keys_str_mv AT bruscolinialice managementofpatientswithgravesdiseaseandorbitalinvolvementroleofspectraldomainopticalcoherencetomography
AT lacavamaurizio managementofpatientswithgravesdiseaseandorbitalinvolvementroleofspectraldomainopticalcoherencetomography
AT gharbiyamagda managementofpatientswithgravesdiseaseandorbitalinvolvementroleofspectraldomainopticalcoherencetomography
AT sacchettimarta managementofpatientswithgravesdiseaseandorbitalinvolvementroleofspectraldomainopticalcoherencetomography
AT restivolucia managementofpatientswithgravesdiseaseandorbitalinvolvementroleofspectraldomainopticalcoherencetomography
AT nardellachiara managementofpatientswithgravesdiseaseandorbitalinvolvementroleofspectraldomainopticalcoherencetomography
AT marencomarco managementofpatientswithgravesdiseaseandorbitalinvolvementroleofspectraldomainopticalcoherencetomography
AT lambiasealessandro managementofpatientswithgravesdiseaseandorbitalinvolvementroleofspectraldomainopticalcoherencetomography